PositiveID Corporation Announces First Quarter 2012 Accomplishments: Positions Itself for $3 Billion BioWatch Contract and Advances the Development of Its Diabetes Management Products DELRAY BEACH, Fla., April 2, 2012 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCBB:PSID), an emerging growth company and developer of advanced technologies for diabetes...

PositiveID Corporation Finalizes First-in-Class Development of a Fully Synthetic Glucose Sensing System, a Critical Component of an Artificial Pancreas DELRAY BEACH, Fla., March 5, 2012 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID") (OTCBB:PSID), a developer of medical technologies for diabetes management, announced today that it has...

PositiveID Achieves Positive Preliminary Results From Diabetes Research Institute Study at the University of Miami DELRAY BEACH, Fla., Feb. 13, 2012 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID") (OTCBB:PSID), a developer of medical technologies for diabetes management, announced today positive...

PositiveID Corporation Successfully Completes Phase II of Its GlucoChip Glucose-Sensing Microchip for Patients With Diabetes Laboratory testing proves glucose-sensing system produces a measurable response to changing glucose levels in human blood matrix Companies publish results of testing in white paper, available at...

PositiveID Corporation Successfully Completes Development of Its Continuous Glucose Sensor to Accurately Measure Glucose Levels in Human Blood DELRAY BEACH, Fla., July 14, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (Nasdaq:PSID), a developer of medical technologies for diabetes management, clinical...